Nikko Asset Management Amends PacBio Stake as of Dec 31, 2023

Ticker: PACB · Form: SC 13G/A · Filed: 2024-02-12T00:00:00.000Z

Sentiment: neutral

Topics: institutional-ownership, amendment, investor-update

TL;DR

**Nikko Asset Management updated its PacBio holdings, signaling a potential shift in institutional confidence.**

AI Summary

Nikko Asset Management Americas, Inc. filed an amended SC 13G/A on February 12, 2024, indicating their ownership of Pacific Biosciences of California, Inc. common stock as of December 31, 2023. This filing is an amendment (Amendment No. 2), suggesting a change in their previously reported holdings. Investors should note that Nikko Asset Management Americas, Inc. is a significant institutional holder, and changes in their position can signal their confidence or concerns about the company's future prospects.

Why It Matters

This filing shows an institutional investor's updated position in Pacific Biosciences, which can influence market sentiment and potentially the stock price.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of institutional ownership and does not inherently present a direct risk to the company or its investors.

Analyst Insight

Investors should monitor subsequent filings from Nikko Asset Management Americas, Inc. to track their evolving position in Pacific Biosciences and consider this information alongside other fundamental and technical analysis.

Key Players & Entities

FAQ

What type of filing is this document?

This document is an SC 13G/A, which is an amendment to a Schedule 13G, as indicated by 'FORM TYPE: SC 13G/A' and '(Amendment No. 2)*' in the filing.

Who is the reporting person in this filing?

The reporting person is Nikko Asset Management Americas, Inc., as stated under 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Nikko Asset Management Americas, Inc.'

What is the subject company whose securities are being reported?

The subject company is Pacific Biosciences of California, Inc., identified under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'

What is the CUSIP number for the class of securities reported?

The CUSIP number for the Common Stock, par value $0.001 per share, is 69404D108, as listed under 'CUSIP Number'.

What was the date of the event that triggered this filing?

The date of the event which requires the filing of this statement was December 31, 2023, as specified in the filing.

From the Filing

0001140361-24-007054.txt : 20240212 0001140361-24-007054.hdr.sgml : 20240212 20240212171209 ACCESSION NUMBER: 0001140361-24-007054 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240212 DATE AS OF CHANGE: 20240212 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA, INC. CENTRAL INDEX KEY: 0001299130 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 161590339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-85738 FILM NUMBER: 24621199 BUSINESS ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-521-8000 MAIL ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA INC DATE OF NAME CHANGE: 20050829 FORMER COMPANY: FORMER CONFORMED NAME: NANOFLUIDICS INC DATE OF NAME CHANGE: 20040729 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Nikko Asset Management Americas, Inc. CENTRAL INDEX KEY: 0001480751 ORGANIZATION NAME: IRS NUMBER: 941302123 STATE OF INCORPORATION: DE FISCAL YEAR END: 0310 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 605 THIRD AVENUE STREET 2: 38TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10158 BUSINESS PHONE: 212-610-6100 MAIL ADDRESS: STREET 1: 605 THIRD AVENUE STREET 2: 38TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10158 SC 13G/A 1 ef20021452_sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Pacific Biosciences of California, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 69404D108 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(b) ☐ Rule 13d-1(c) ☐ Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 1 NAMES OF REPORTING PERSONS     Nikko Asset Management Americas, Inc.         2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP     (a)☐     (b) ☐     3 SEC USE ONLY             4 CITIZENSHIP OR PLACE OF ORGANIZATION     USA         NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER     0         6 SHARED VOTING POWER     12,270,457         7 SOLE DISPOSITIVE POWER     0         8 SHARED DISPOSITIVE POWER     13,200,375         9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON     13,200,375         10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)     ☐         11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)     4.93%         12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)     IA         Item 1.   (a) Name of Issuer   Pacific Biosciences of California, I

View on Read The Filing